$FORW Forwardly, Inc.
@ForwardlyInc
·
Nov 9
$FORW is pleased to announce that Ligand Innovation Global has been invited by the US FDA for a review of the application seeking approval for the VitaCaeli G1 Ventilator via video conference on Friday 18th November at 11AM EST.
Breathe Medical Devices, Inc.
• a wholly owned subsidiary corporation
June 1, 2020 Forwardly, Inc. formed "Breathe Medical Devices, Inc.", a wholly owned Wyoming corporation.
This subsidiary will be the operating arm for Forwardly's recent acquisition of the exclusive US distribution rights to VitaCaeli™ (LifeAir), a patent pending, non-invasive ventilator currently under development by Ligand Innovation Global, a Canadian corporation. A newer iteration of the VitaCaeli™ (LifeAir) ventilator has been engineered for a summer 2022 submission to the US Food and Drug Administration ("FDA") and Canada Health in the hopes of obtaining fast track approval. A demonstration of a prototype of the VitaCaeli™ (LifeAir) ventilator is available for viewing at www.LigandGlobal.com
The new subsidiary will at least initially be managed by Mr. Sharp, however, the company is currently reviewing the new asset with several prominent doctors and has formed a Medical Advisory Board.
Update: As of April 9, 2021 – Forwardly, Inc. owns 33.3% of Ligand Global Innovation.
